Willke RJ - Search Results

1

Linked Pharmacometric-Pharmacoeconomic Modeling and Simulation in Clinical Drug Development.

Hill-McManus D, Marshall S, Liu J, Willke RJ, Hughes DA. Hill-McManus D, et al. Among authors: willke rj. Clin Pharmacol Ther. 2021 Jul;110(1):49-63. doi: 10.1002/cpt.2051. Epub 2020 Oct 26. Clin Pharmacol Ther. 2021. PMID: 32936931 Review.

2

Comparative efficacy and effectiveness: an opportunity for clinical pharmacology.

Lalonde RL, Willke RJ. Lalonde RL, et al. Among authors: willke rj. Clin Pharmacol Ther. 2011 Dec;90(6):761-3. doi: 10.1038/clpt.2011.240. Clin Pharmacol Ther. 2011. PMID: 22089338

3

Translating Pharmacometrics to a Pharmacoeconomic Model of COPD.

Slejko JF, Willke RJ, Ribbing J, Milligan P. Slejko JF, et al. Among authors: willke rj. Value Health. 2016 Dec;19(8):1026-1032. doi: 10.1016/j.jval.2016.07.006. Epub 2016 Sep 21. Value Health. 2016. PMID: 27987629 Free article.

4

Real World Data in Adaptive Biomedical Innovation: A Framework for Generating Evidence Fit for Decision-Making.

Schneeweiss S, Eichler HG, Garcia-Altes A, Chinn C, Eggimann AV, Garner S, Goettsch W, Lim R, Löbker W, Martin D, Müller T, Park BJ, Platt R, Priddy S, Ruhl M, Spooner A, Vannieuwenhuyse B, Willke RJ. Schneeweiss S, et al. Among authors: willke rj. Clin Pharmacol Ther. 2016 Dec;100(6):633-646. doi: 10.1002/cpt.512. Epub 2016 Oct 19. Clin Pharmacol Ther. 2016. PMID: 27627027

5

Reflections on the ISPOR Special Task Force on U.S. Value Frameworks: Implications of a Health Economics Approach for Managed Care Pharmacy.

Garrison LP Jr, Neumann PJ, Willke RJ. Garrison LP Jr, et al. Among authors: willke rj. J Manag Care Spec Pharm. 2019 Nov;25(11):1185-1192. doi: 10.18553/jmcp.2019.25.11.1185. J Manag Care Spec Pharm. 2019. PMID: 31663458 Free PMC article.

6

Review of Recent US Value Frameworks-A Health Economics Approach: An ISPOR Special Task Force Report [6].

Willke RJ, Neumann PJ, Garrison LP Jr, Ramsey SD. Willke RJ, et al. Value Health. 2018 Feb;21(2):155-160. doi: 10.1016/j.jval.2017.12.011. Value Health. 2018. PMID: 29477393 Free article.

7

CHEERS to Updated Guidelines for Reporting Health Economic Evaluations!

Willke RJ, Pizzi LT. Willke RJ, et al. Value Health. 2022 Jan;25(1):1-2. doi: 10.1016/j.jval.2021.11.1350. Value Health. 2022. PMID: 35031087 Free article. No abstract available.

8

A Health Economics Approach to US Value Assessment Frameworks-Introduction: An ISPOR Special Task Force Report [1].

Neumann PJ, Willke RJ, Garrison LP Jr. Neumann PJ, et al. Among authors: willke rj. Value Health. 2018 Feb;21(2):119-123. doi: 10.1016/j.jval.2017.12.012. Value Health. 2018. PMID: 29477388 Free article.

9

An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report [2].

Garrison LP Jr, Pauly MV, Willke RJ, Neumann PJ. Garrison LP Jr, et al. Among authors: willke rj. Value Health. 2018 Feb;21(2):124-130. doi: 10.1016/j.jval.2017.12.006. Value Health. 2018. PMID: 29477389 Free article.

10

A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7].

Garrison LP Jr, Neumann PJ, Willke RJ, Basu A, Danzon PM, Doshi JA, Drummond MF, Lakdawalla DN, Pauly MV, Phelps CE, Ramsey SD, Towse A, Weinstein MC. Garrison LP Jr, et al. Among authors: willke rj. Value Health. 2018 Feb;21(2):161-165. doi: 10.1016/j.jval.2017.12.009. Value Health. 2018. PMID: 29477394 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters